Microbiota-targeted interventions, including prebiotics, probiotics, and fecal microbiota transplantation (FMT), have demonstrated metabolic benefits [61], with FMT from lean donors significantly improving peripheral insulin sensitivity in individuals with metabolic syndrome [67]. This evidence concerns the gene INS and metabolic syndrome.